Orientations
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19, updated 18 August 2022
These are the annexes to WHO interim recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 vaccine against Covid-19. Annexes 1–6 contain tables that summarize the grading of recommendations, assessment, development and evaluations (GRADE). Annexes 7–9 contain the SAGE evidence-to-recommendation framework tables (ETR tables).
GRADE and ETR tables are updated as recommendations are updated.
This document has been updated: Version 21 January 2022.
Auteurs
Langues
- Anglais
Année de publication
2021
Type
Orientations
Catégories
- Vaccins et dispositifs d'administration
Maladies
- COVID-19